Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report

doi:10.4251/wjgo.v17.i9.108960

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(50)

(45)

(0)

(9)

(663)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108960
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108960

Full Size Figure Download Figure

Figure 4 Endoscopic retrograde cholangiopancreatography revealed an irregular contrast defect in the middle and lower part of the common bile duct and multifocal narrowing and dilatation in the upper part of the bile duct.

Citation: Gao Z, Zhang JX, Tian XD, Wu SK, Jin X. Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report. World J Gastrointest Oncol 2025; 17(9): 108960
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/108960.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.108960

Gao Z, Zhang JX, Tian XD, Wu SK, Jin X. Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report. World J Gastrointest Oncol 2025; 17(9): 108960 [PMID: 40977641 DOI: 10.4251/wjgo.v17.i9.108960]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.